[1]
2009. Current status of anti-CD30 monoclonal antibody therapy in anaplastic lymphoma and Hodgkin’s lymphoma. Hematology Meeting Reports (formerly Haematologica Reports). 2, 13 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i13.483.